Blue Owl Healthcare Opportunities

New York, NY, US

Thesis

Mid-to-late-stage equity and royalty investments in biopharma, diagnostics, and digital medicine companies.

Stages

GrowthSeries BSeries C

Sectors

BiotechLife SciencesHealthcare/MedtechHealth and Wellness

Current fund: Blue Owl Healthcare Opportunities Fund IV (fka Cowen Healthcare Investments IV) · 2023 · $$555.6M
AUM: $$1B+ (Healthcare Opportunities strategy); ~$295B firmwide Blue Owl

Israeli medical-device innovation house that invents, patents, and builds proprietary medtech startups.…

AI and robotics applied to transform foundational industries vertical by vertical.…

Growth-stage investor backing category-leading cannabis and cannabis-adjacent companies navigating evolving regulation.…